
Pharmaceutical Company In Senegal Produces First African-Made Clinical Treatment For Sickle Cell
A Senegalese pharmaceutical company is behind a new generic drug for sickle cell disease. As AFROTECH™ previously reported, sickle cell disease is a genetic disorder that causes red blood cells to become abnormally shaped. The cell takes on a crescent or “sickle” shape, making it harder for blood to flow through the body. This causes… Continue reading Pharmaceutical Company In Senegal Produces First African-Made Clinical Treatment For Sickle Cell











